Suchergebnisse - "Davies, Michael"

PubPharm (14)

1

Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls

enthalten in: Cancer | 2024

von Zhao, X. | Yang, M. | Fan, J. | +45

CommentIn: Cancer. 2024 Mar 15;130(6):848-850. - PMID 38236782

2

Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti-CTLA4 and anti-PD1 combination immunotherapy : Incidence, management, and clinical benefit

enthalten in: Cancer | 2022

von Patel, A. | Farooq, S. | Welborn, M. | +15

3

Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti‐CTLA4 and anti‐PD1 combination immunotherapy : Incidence, management, and clinical benefit

enthalten in: Cancer | 2022

von Patel, A. | Farooq, S. | Welborn, M. | +15

4

Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases : A case series

enthalten in: Cancer | 2020

von Holbrook, K. | Lutzky, J. | Davies, M. | +7

5

Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti-PD-1 in patients with metastatic melanoma

enthalten in: Cancer | 2019

von Schvartsman, G. | Ma, J. | Bassett, R. | +11

6

Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti–PD‐1 in patients with metastatic melanoma

enthalten in: Cancer | 2019

von Schvartsman, G. | Ma, J. | Bassett, R. | +11

7

First-in-human trial of the PI3Kβ-selective inhibitor SAR260301 in patients with advanced solid tumors

enthalten in: Cancer | 2018

von Bédard, P. | Davies, M. | Kopetz, S. | +13

8

Clinicopathological features and clinical outcomes associated with TP53 and BRAFNon-V600 mutations in cutaneous melanoma patients

enthalten in: Cancer | 2017

von Kim, D. | Haydu, L. | Joon, A. | +15

9

Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanoma

enthalten in: Cancer | 2013

von Bucheit, A. | Syklawer, E. | Jakob, J. | +7

10

Clinical responses to selumetinib (AZD6244; ARRY-142886)-based combination therapy stratified by gene mutations in patients with metastatic melanoma

enthalten in: Cancer | 2013

von Patel, S. | Lazar, A. | Papadopoulos, N. | +8